Edition:
United States

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

747.50GBp
14 Dec 2017
Change (% chg)

-2.50 (-0.33%)
Prev Close
750.00
Open
747.50
Day's High
751.00
Day's Low
743.50
Volume
67,955
Avg. Vol
627,210
52-wk High
779.00
52-wk Low
528.36

Chart for

About

BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and... (more)

Overall

Beta: 0.16
Market Cap(Mil.): £2,898.10
Shares Outstanding(Mil.): 386.41
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.96 15.25
EPS (TTM): -- -- --
ROI: -- 15.07 33.27
ROE: -- 16.58 16.35

BRIEF-BTG says CFO Rolf Soderstrom to step down as executive director

* THAT AFTER 10 YEARS AS CHIEF FINANCIAL OFFICER (CFO) AT BTG, ROLF SODERSTROM IS TO STEP DOWN AS AN EXECUTIVE DIRECTOR OF COMPANY​

Nov 14 2017

BRIEF-BTG H1 ‍adjusted operating profit of 99.1 mln stg vs 78.8 mln stg

* H1 ‍ADJUSTED OPERATING PROFIT OF 99.1 MILLION STG VERSUS 78.8 MILLION STG YEAR AGO​

Nov 14 2017

BRIEF-BTG receives CPT codes for health insurance Varithena

* ‍new payment rates and automatic electronic processing of claims effective 1 january 2018​

Nov 06 2017

UK's BTG to buy Roxwood Medical for up to $80 million

British drugs company BTG Plc said on Thursday it will buy U.S.-based cardiovascular catheter maker Roxwood Medical for up to $80 million.

Oct 05 2017

UK's BTG to buy Roxwood Medical for up to $80 mln

Oct 5 British drugs company BTG Plc said on Thursday it will buy U.S.-based cardiovascular catheter maker Roxwood Medical for up to $80 million.

Oct 05 2017

BRIEF-BTG acquires Roxwood Medical

* ACQUIRED ROXWOOD MEDICAL, A PROVIDER OF ADVANCED CARDIOVASCULAR SPECIALTY CATHETERS

Oct 05 2017

BRIEF-BTG Plc reiterates full year product sales guidance

* ‍SPECIALTY PHARMACEUTICALS IS EXPECTED TO GROW BY LOW-TO-MID SINGLE DIGITS AT CER IN FY, WEIGHTED AS EXPECTED TO FIRST HALF.​

Oct 05 2017

BTG ordered to pay damages of $55.8 mln to Wellstat

LONDON, Sept 20 British drugs company BTG has been ordered to pay damages of $55.8 million plus interest and costs to Wellstat Therapeutics in a dispute over the distribution of Vistogard, an antidote to the overdose of two chemotherapy drugs.

Sep 20 2017

BRIEF-BTG ordered to pay damages of $55.8 mln to Wellstat Therapeutics

* ‍a memorandum opinion has been issued against btg in its previously announced litigation with wellstat therapeutics corporation​

Sep 20 2017

BRIEF-BTG says trading since April 1 in line with expectations

* Our strong performance in 2016/17 has continued into new financial year

Jul 13 2017

Earnings vs. Estimates